New Brain Metastasis Research Reported from New York University NYU Langone Health (Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of...).

Předmět:	BRAIN metastasis RADIOTHERAPY MONOCLONAL antibodies PROGNOSIS
Zdroj:	Immunotherapy Weekly; 3/6/2023, p1063-1063, 1p
Abstrakt:	Keywords: Antineoplastic Monoclonal Antibodies; Antineoplastics; Bevacizumab Therapy; Brain Diseases and Conditions; Brain Metastasis; Drugs and Therapies; Health and Medicine; Immunologic Agents; Monoclonal Antibodies; Pharmaceuticals; Radiotherapy; Tyrosine Kinase Inhibitors; VEGF - VEGFR Inhibitors; VEGFR Inhibitors EN Antineoplastic Monoclonal Antibodies Antineoplastics Bevacizumab Therapy Brain Diseases and Conditions Brain Metastasis Drugs and Therapies Health and Medicine Immunologic Agents Monoclonal Antibodies Pharmaceuticals Radiotherapy Tyrosine Kinase Inhibitors VEGF - VEGFR Inhibitors VEGFR Inhibitors 1063 1063 1 03/24/23 20230306 NES 230306 2023 MAR 10 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Research findings on brain metastasis are discussed in a new report. Antineoplastic Monoclonal Antibodies, Antineoplastics, Bevacizumab Therapy, Brain Diseases and Conditions, Brain Metastasis, Drugs and Therapies, Health and Medicine, Immunologic Agents, Monoclonal Antibodies, Pharmaceuticals, Radiotherapy, Tyrosine Kinase Inhibitors, VEGF - VEGFR Inhibitors, VEGFR Inhibitors. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu